CHEMED CORP (CHE) Fundamental Analysis & Valuation

NYSE:CHE • US16359R1032

Current stock price

398.33 USD
-3.54 (-0.88%)
At close:
398.33 USD
0 (0%)
After Hours:

This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CHE Profitability Analysis

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • CHE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CHE had a positive operating cash flow.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • With an excellent Return On Assets value of 17.24%, CHE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Return On Equity of CHE (27.08%) is better than 92.08% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 21.08%, CHE belongs to the top of the industry, outperforming 95.05% of the companies in the same industry.
  • CHE had an Average Return On Invested Capital over the past 3 years of 21.04%. This is significantly above the industry average of 8.92%.
  • The 3 year average ROIC (21.04%) for CHE is below the current ROIC(21.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROIC 21.08%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.48%, CHE belongs to the top of the industry, outperforming 96.04% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CHE has declined.
  • The Operating Margin of CHE (14.01%) is better than 86.14% of its industry peers.
  • CHE's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 32.54%, CHE is doing good in the industry, outperforming 63.37% of the companies in the same industry.
  • CHE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CHE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
  • Compared to 1 year ago, CHE has less shares outstanding
  • The number of shares outstanding for CHE has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CHE has a worse debt to assets ratio.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CHE has an Altman-Z score of 11.05. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
  • CHE has a Altman-Z score of 11.05. This is amongst the best in the industry. CHE outperforms 97.03% of its industry peers.
  • CHE has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.03, CHE belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
  • CHE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • CHE has a better Debt to Equity ratio (0.01) than 84.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Altman-Z 11.05
ROIC/WACC2.36
WACC8.93%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that CHE should not have too much problems paying its short term obligations.
  • The Current ratio of CHE (1.05) is worse than 64.36% of its industry peers.
  • CHE has a Quick Ratio of 1.03. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • CHE's Quick ratio of 1.03 is on the low side compared to the rest of the industry. CHE is outperformed by 61.39% of its industry peers.
  • The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.03
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CHE Growth Analysis

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.70%.
  • Measured over the past 5 years, CHE shows a small growth in Earnings Per Share. The EPS has been growing by 3.61% on average per year.
  • The Revenue has been growing slightly by 4.06% in the past year.
  • Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.00% on average per year.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%

3.2 Future

  • CHE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.57% yearly.
  • CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.60% yearly.
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

5

4. CHE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.45, which indicates a rather expensive current valuation of CHE.
  • CHE's Price/Earnings ratio is a bit cheaper when compared to the industry. CHE is cheaper than 70.30% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CHE to the average of the S&P500 Index (25.96), we can say CHE is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 16.43, the valuation of CHE can be described as correct.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than the industry average as 71.29% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of CHE to the average of the S&P500 Index (24.04), we can say CHE is valued slightly cheaper.
Industry RankSector Rank
PE 18.45
Fwd PE 16.43
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CHE.
  • Based on the Price/Free Cash Flow ratio, CHE is valued a bit cheaper than the industry average as 68.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.85
EV/EBITDA 13.02
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.5
PEG (5Y)5.11
EPS Next 2Y12.04%
EPS Next 3Y10.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CHE Dividend Analysis

5.1 Amount

  • CHE has a yearly dividend return of 0.60%, which is pretty low.
  • CHE's Dividend Yield is rather good when compared to the industry average which is at 0.50. CHE pays more dividend than 82.18% of the companies in the same industry.
  • With a Dividend Yield of 0.60, CHE pays less dividend than the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 0.6%

5.2 History

  • On average, the dividend of CHE grows each year by 11.06%, which is quite nice.
  • CHE has paid a dividend for at least 10 years, which is a reliable track record.
  • CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.06%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 11.95% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
  • The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CHE Fundamentals: All Metrics, Ratios and Statistics

CHEMED CORP

NYSE:CHE (3/16/2026, 7:15:02 PM)

After market: 398.33 0 (0%)

398.33

-3.54 (-0.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners101.6%
Inst Owner Change42.44%
Ins Owners1.54%
Ins Owner Change-1.94%
Market Cap5.49B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target566.61 (42.25%)
Short Float %3.43%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0.6%
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)0%
PT rev (3m)-3.27%
EPS NQ rev (1m)-8.48%
EPS NQ rev (3m)-8.48%
EPS NY rev (1m)-5.51%
EPS NY rev (3m)-5.76%
Revenue NQ rev (1m)-2.43%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-1.39%
Valuation
Industry RankSector Rank
PE 18.45
Fwd PE 16.43
P/S 2.17
P/FCF 16.85
P/OCF 14.13
P/B 5.6
P/tB 23.88
EV/EBITDA 13.02
EPS(TTM)21.59
EY5.42%
EPS(NY)24.25
Fwd EY6.09%
FCF(TTM)23.64
FCFY5.93%
OCF(TTM)28.2
OCFY7.08%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.5
PEG (5Y)5.11
Graham Number185.88
Profitability
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROCE 28.33%
ROIC 21.08%
ROICexc 22.41%
ROICexgc 60.78%
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
FCFM 12.86%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Debt/EBITDA 0.03
Cap/Depr 96.84%
Cap/Sales 2.48%
Interest Coverage 263.51
Cash Conversion 92.61%
Profit Quality 122.71%
Current Ratio 1.05
Quick Ratio 1.03
Altman-Z 11.05
F-Score6
WACC8.93%
ROIC/WACC2.36
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.84%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%

CHEMED CORP / CHE Fundamental Analysis FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 8 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 8 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to grow by 12.32% in the next year.